- TelyRx (TSX:TELY) recently filled its one millionth prescription, furthering the company’s mission of expanding access to medications across the United States.
- TelyRx Holdings is a healthcare and pharmacy services technology company connecting patients with state-licensed providers across 48 US states and territories.
- The micro-cap healthcare stock is up by 11.36 per cent on the news trading at C$2.45 as of 9:35 am ET.
Online pharmacy platform TelyRx (TSX:TELY) recently filled its one millionth prescription, furthering the company’s mission of expanding access to medications across the United States.
This article is a journalistic opinion piece which has been written based on independent research. It is intended to inform investors and should not be taken as a recommendation or financial advice.
The company chalks up the milestone to its easy-to-use interface, simple cash-pay model connecting patients with healthcare providers and pharmacy services, as well as its diversified access to more than 450 FDA-approved medications and treatments for more than 60 acute and chronic conditions, from allergies and asthma, to diabetes, infections and sexual health, a value proposition that is delivering “strong repeat engagement across the platform”, according to Monday’s news release.
TelyRX is marking the occasion with a sitewide discount and referral incentive to foster further growth, keen to leverage an existing physician and pharmacy network capable of serving more than 97 per cent of the US population.
The company nearly tripled revenue year-over-year in Q1 2026 to US$19.4 million , supported by a solid gross margin of 55 per cent, up by 5 per cent year-over-year, with US$27 million in cash and equivalents on the books to continue growing its customer base.
Leadership commentary
“Reaching one million prescriptions is a meaningful milestone for TelyRx and an opportunity to thank our customers,” Vanessa Slowey, President and Chief Executive Officer of TelyRx, said in a statement. “Consumers are looking for healthcare that is easier to access, simpler to navigate and more reliable. The strongest signal for us is not the first prescription, it’s that patients come back again and again.”
About TelyRx
TelyRx Holdings is a healthcare and pharmacy services technology company connecting patients with state-licensed providers across 48 US states and territories.
TelyRx stock (TSX:TELY) is up by 11.36 per cent on the news trading at C$2.45 as of 9:35 am ET.
Join the discussion: Find out what investors are saying about this micro-cap healthcare technology stock on the TelyRx Holdings Inc. Bullboard and make sure to explore the rest of Stockhouse’s stock forums and message boards.